Your browser doesn't support javascript.
loading
ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trial.
Hu, Yue; Li, Haijun; Zhang, Hong; Chen, Xiaoxin; Chen, Jinjun; Xu, Zhongyuan; You, Hong; Dong, Ruihua; Peng, Yun; Li, Jing; Li, Xiaojiao; Wu, Dandan; Zhang, Lei; Cao, Di; Jin, He; Qiu, Dongdong; Yang, Aruhan; Lou, Jinfeng; Zhu, Xiaoxue; Niu, Junqi; Ding, Yanhua.
Afiliación
  • Hu Y; Phase I Clinical Research Center, First Hospital of Jilin University, Changchun, China.
  • Li H; Guangdong Raynovent Biotech Co., Ltd, Guangzhou, China.
  • Zhang H; Department of Anatomy and Neurobiology, School of Basic Medical Science, Central South University, Changsha, China.
  • Chen X; Phase I Clinical Research Center, First Hospital of Jilin University, Changchun, China.
  • Chen J; Guangdong Raynovent Biotech Co., Ltd, Guangzhou, China.
  • Xu Z; Nafang Hospital, Nanfang Medical University, Guangzhou, China.
  • You H; Nafang Hospital, Nanfang Medical University, Guangzhou, China.
  • Dong R; Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Peng Y; Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Li J; Guangdong Raynovent Biotech Co., Ltd, Guangzhou, China.
  • Li X; Guangdong Raynovent Biotech Co., Ltd, Guangzhou, China.
  • Wu D; Phase I Clinical Research Center, First Hospital of Jilin University, Changchun, China.
  • Zhang L; Phase I Clinical Research Center, First Hospital of Jilin University, Changchun, China.
  • Cao D; Department of Radiology, First Hospital of Jilin University, Changchun, China.
  • Jin H; Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Qiu D; Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Yang A; Department of Radiology, First Hospital of Jilin University, Changchun, China.
  • Lou J; Phase I Clinical Research Center, First Hospital of Jilin University, Changchun, China.
  • Zhu X; Phase I Clinical Research Center, First Hospital of Jilin University, Changchun, China.
  • Niu J; Phase I Clinical Research Center, First Hospital of Jilin University, Changchun, China. zhuxiaoxue@jlu.edu.cn.
  • Ding Y; Department of Hepatology, First Hospital of Jilin University, Changchun, China. junqiniu@jlu.edu.cn.
Nat Commun ; 14(1): 6409, 2023 10 12.
Article en En | MEDLINE | ID: mdl-37828034
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad del Hígado Graso no Alcohólico Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad del Hígado Graso no Alcohólico Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2023 Tipo del documento: Article País de afiliación: China